Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Pulmonary Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: a retrospective case series

  • Sergej Griff1Email author,
  • Nicolas Schönfeld2,
  • Wilhelm Ammenwerth2,
  • Torsten-Gerriet Blum2,
  • Christian Grah3,
  • Torsten T Bauer2,
  • Wolfram Grüning4,
  • Thomas Mairinger1 and
  • Henrik Wurps2
BMC Pulmonary Medicine201414:171

https://doi.org/10.1186/1471-2466-14-171

Received: 30 August 2014

Accepted: 23 October 2014

Published: 3 November 2014

Abstract

Background

Due to the small amount of alveolar tissue in transbronchial biopsy (TBB) by forceps, the diagnosis of diffuse, parenchymal lung diseases (DPLD) is inherently problematic, with an overall low yield. The use of cryotechnique in bronchoscopy, including TBB by cryoprobe, has revealed new opportunities in the endoscopical diagnosis of malignant and non-malignant lung diseases.

Methods

To evaluate TBB by cryotechnique for non-neoplastic lung diseases, we analyzed 52 patients (mean age 63 ± 13 years) with unclear DPLD. These individuals underwent bronchoscopy with TBB by cryoprobe. Thereafter histopathological results were compared with the clinically evaluated diagnosis.

Results

No major complications were seen. Mean specimen diameter in the histological biopsies was 6.9 ± 4.4 mm (Range 2 – 22 mm). A correlation between clinical and histopathological diagnoses was found in 79% of cases (41/52). In the case of UIP (usual interstitial pneumonia) pattern, the concordance was 10/15 (66%).

Conclusion

Based on these results TBB by cryotechnique would appear to be a safe and useful method that reveals new perspectives for the endoscopical diagnosis of DPLD.

Keywords

Diffuse parenchymal lung disease (DPLD)BronchoscopyTransbronchial biopsy (TBB)CryotechniqueHistopathologyUsual interstitial pneumonia (UIP)

Background

Concerning transbronchial lung biopsy (TBB) by forceps, histopathological results depend on specimen size and quality, artificial changes due to the procedure itself, and the amount of alveolar tissue contained in the sample. TBB by forceps typically delivers one or more 1–2 mm sized specimen, often with underrepresentation of alveolar tissue [14].

Due to the large variation of indications, as well as different sizes and locations of pulmonary lesions, diagnostic yield of TBB by forceps is severe to describe. Most recent case series specify a diagnostic accuracy of about 50% to 70% [1, 3, 511].

Diffuse parenchymal lung diseases (DPLD) are harder to diagnose by TBB with an overall lower yield. Efficacy variations depend on the underlying disease: Sarcoidosis and cryptogenic organizing pneumonia (COP) render fairly good results, whereas usual interstitial pneumonia (UIP), pneumoconiosis, respiratory bronchiolitis associated interstitial lung disease (RB-ILD), non specific interstitial pneumonia (NSIP) and pulmonary histiocytosis X show poor results [1, 4, 10, 12, 13]. This broad range is explained by the diverging importance of alveolar tissue for the histopathological diagnosis.

Due to the small yield of alveoli in TBB by forceps it is not possible to gather further information concerning the histopathological pattern of affected tissue throughout the lung. This problem is well known and has recently been discussed in literature [1, 3, 4, 6, 1317]. Some papers do show an increase of diagnostic yield depending on the size of the specimen [6, 14], however artificial changes due to TBB by forceps are an important limiting criterion for the pathological diagnosis of DPLD.

Cryobiopsy as a tool in bronchology has been introduced on a routine basis in recent years and has been found to be safe in a routine diagnostic setting [18, 19]. Specimen size has been reported to be larger and diagnostically more valuable due to more alveolar tissue and less artificial changes. In a previous paper morphometrical benefits of cryobioptically obtained lung tissue specimen were shown and perspectives of this method in a daily routine were discussed [20]. There is evidence that cryobiopsies increase efficacy concerning histopathological tumor diagnostics in central malignant lesions [19, 21].

The aim of this study was to evaluate TBB by cryotechnique for non-neoplastic diseases. Our focus was sample adequacy for diagnostic purposes, sample size and proportion of alveolar tissue retrieved, as well as the possibility of histopathological diagnosis of DPLD by cryobiopsy in correlation to clinical diagnoses.

Methods

This is a retrospective case series (June 2009 – December 2011) of 52 patients with diffuse, interstitial, non-neoplastic lung diseases who underwent flexible, fiberoptic bronchoscopy with transbronchial cryobiopsy. Additionally, all patients had routine diagnostics including lung function evaluation, chest x-ray and thoracic computed tomography (CT-scan).

For the transbronchial cryobiopsy a flexible cryoprobe with a diameter of 1.9 mm was used (flexible Kryosonde diameter 1.9 mm length 900 mm, Erbe Elektromedizin GmbH, Tübingen, Germany), the probe was cooled to a temperature of about – 77°C by carbon dioxide. The flexible bronchoscopy (1 T 160 and 1 T 180, Olympus Corp. Tokyo Japan) was performed under sedation with disoprivan or midazolam and local anaesthesia with lidocaine. The cryoprobe was introduced into the selected area with a distance of approximately 1–2 cm from the thoracic wall under radiological guidance. In this position the cryoprobe was cooled for three to five seconds and then retracted with the attached frozen lung tissue. For each patient one to two specimen were taken and then fixed in 4% buffered formalin.

To avoid incomplete sectioning of specimen particles all biopsies were conventionally processed by serial sectioning of at least 12 H & E stained section steps. Concerning quantity, quality (number of artefacts), and the amount of alveolar tissue, the biopsies were rated by two experienced lung pathologists (SG & TM).

Mirax Viewer Image Software Ver (1, 6) was used for scanning the Hematoxylin-eosine slides by a ZEISS-MIRAX Midi Slide scanning system (Zeiss Microimaging, Oberkochen, Germany and 3DTech, Budapest, Hungary). The total diameter of the biopsy specimens were measured and expressed in μm.

Histopathological changes were rated according to criteria for UIP diagnosis based on the Official ATS/ERS/JRS/ALAT Statement (22). The histological diagnosis of other entities was made by the use of classical criteria for interstial lung diseases (4).

Histopathological results and radiographic images were compared to the patients’ medical history, physical examination and data of pulmonary lung function testing. At last, in an interdisciplinary setting (pathologist, radiologist, pneumologist) a diagnosis was found. Furthermore, complications seen during bronchoscopy were rated.

Statistically, results were expressed as frequencies or as mean ± SD. Chi-square-test was used to compare proportions. The significance level of the analyses was set to 5%, and exact p values were reported. Results were expressed using descriptive statistics.

Statistical software (Statistical Package for Social Sciences, Version 14.0; SPSS, Chicago, IL, USA) was used to analyze and process the data on a Windows XP operating system (Microsoft; Redmond, WA, USA).

A waiver for this study was received by the ethics committee of the Charité, Berlin, Germany (“Ethikkommission, Ethikausschuss 1 am Campus Charité – Mitte”) on January 23, 2014.

Results

Overall, 52 patients with a median age of 63 ± 13 years were analyzed. 36/52 (69%) patients were male, 16/52 (31%) were female. In 41/52 cases (79%) a correlation with clinical and histopathological diagnosis was found. In 11/52 cases (21%) no match could be achieved.

Mean specimen diameter in the histological biopsies was 6.9 ± 4.4 mm (Range 2 – 22 mm). In the specimen, alveolar tissue was found in 48/52 (92%) cases. In 4/52 (8%) cases no alveolar tissue was found. In one of these four cases no histopathological diagnosis could be matched to the clinical diagnosis due to the lack of alveolar tissue. In the other three cases the diagnosis was sarcoidosis, and typical granulomas were found in the bronchial mucosa. The specimens lacking alveolar tissue either contained only bronchial mucosa and sometimes cartilage, or presented themselves as long flat bands of inner bronchial wall lining.

No major complications (pneumothorax, major bleeding >3 minutes) with need of further intervention were reported.

Table 1 shows the list of clinically diagnosed lung diseases, the number of matching histopathological findings and the average diagnostic yield of TBB by forceps reported in literature.
Table 1

Comparison of clinically diagnosed DPLD (with number of cases and matching histopathological findings) and averagely reported diagnostic yield by forceps biopsy

Clinical diagnosis

Number of cases

Matching histopathological findings

Average reported diagnostic yield by forceps biopsy

COP

9

8/9 (89%)

65% (10, 27, 28)

Rheumatoid lung disease

2

2/2 (100%)

 

Sarcoidosis

12

10/12 (83%)

69% (10, 28, 29)

Alveolar microlithiasis

1

1/1 (100%)

-

NSIP

1

1/1 (100%)

-

medically-induced lung damages

2

2/2 (100%)

-

HP

7

6/7 (86%)

95% (10)

Pulmonary manifestation of scleroderma

2

1/2 (50%)

-

Histiocytosis

2

1/2 (50%)

-

pANCA-pos. Vasculitis

1

0/1 (0%)

-

IPF

13

9/13 (69%)

34% (1, 10)

The HR-CT images of patients who had the clincal diagnosis of idiopathical lung fibrosis (IPF) or pulmonary manifestation of scleroderma were rated apropos of the radiological criteria for UIP after ATS (American Thoracic Society) and ERS (European Respiratory Society) [22, 23]. Of these fifteen cases, fourteen (93%) showed possible or probable UIP pattern and one (7%) was inconsistent with UIP pattern.

Discussion

Cryobiopsy in our series proved to be a sufficient tool in the diagnostic processing for various diffuse, parenchymal lung diseases (DPLD). Specifically, the highest diagnostic yields were achieved in patients with sarcoidosis (83%), COP (89%), and hypersensitivity pneumonia (HP, 86%). Comparable results with the use of transbronchial forceps biopsy have been reported in recent years [1, 3, 510] (see Table 1). These good results are probably due to the location of granulomatous or other characteristic changes close to or within the bronchial wall.

Nevertheless clear distinctions became obvious between diseases that required the recognition of a gross histological pattern (UIP, NSIP, RB-ILD) and all others.

It has generally been assumed that transbronchial lung biopsies cannot be used for the diagnosis of UIP [10]. A hallmark characteristic of UIP is the patchy involvement of lung tissue, so that areas of involved parenchyma and unaffected alveoli stand next to each other. Furthermore, UIP is characterized histologically by fibrosis and chronic inflammation, i.e. features that are usual unspecific findings located in the peribronchial tissue.

In a study by Berbescu et al. [1], 22 patients with UIP pattern assessed by open lung biopsy were retrospectively analyzed concerning a pre-op achieved TBB. This revealed a characteristic histopathological UIP pattern in nine cases. Berbescu et al. concluded [1] that certain characteristic features of UIP, such as the patchwork pattern of involvement by fibrosis and temporal variability with fibroblast foci, collagen, and honeycomb changes, previously thought to be recognizable only on surgical lung biopsy specimen, can sometimes be seen on TBB specimen. The patchwork pattern is typically characterized by normal alveoli in close relation to areas of interstitial fibrosis. Its presence helps to distinguish the changes to nonspecific peribronchial fibrosis where there is a gradual transition from normal to abnormal.

In our series of transbronchial cryobiopsies an UIP pattern was diagnosed in two-thirds (10/15, 67%) of the cases (IPF, pulmonary manifestation of scleroderma, see Table 1). This improves the diagnostic yield of TBB for UIP pattern in comparison to data described in literature by up to 50% (see Table 1).

Cryobiopsy specimen tend to be even larger than transbronchial forceps biopsy specimen, and contain more and larger amounts of alveolar tissue [21]. In a previous study the number of alveolar spaces necessary for an adequate biopsy was defined as 20 [6]. This criterion is likely to be fulfilled in most of the cryobiopsy specimen ([21]; unpublished data). However, transbronchial cryobiopsy, as well as TBB by forceps, fail to deliver the diagnosis of UIP in a significant proportion of patients. This may be due to the distance seen frequently between the bronchial wall and typical histological changes, such as fibroblast foci, which are located deeply in the alveolar parenchyma [1] (Figures 1, 2, 3, 4).
Figure 1

Comparison of TBB by cryoprobe (left) and forceps (right): significant differences in size and quality.

Figure 2

Patient with radiological UIP pattern. Overview of transbronchial cryobiopsy: patchy involvement of fibrosing process next to unaffected lung tissue.

Figure 3

Transbronchial cryobiopsy: architectural distortion of lung tissue with scaring next to normal lung parenchyma.

Figure 4

Transbronchial cryobiopsy: active ongoing fibrosis (fibroblast focus) as an expression of “temporary variegation”.

Despite the encouraging findings about cryobiopsy these results do not yet command a recommendation of transbronchial cryobiopsy as a standard procedure in the processing of suspected pulmonary fibrosis. Nevertheless, the current problem of distinguishing between HP with UIP pattern and IPF (which radiologically speaking cannot be securely discriminated [24]) could be solved by the use of cryobiopsy with greater specimen size. Furthermore, there is a greater chance for detection of granulomas or other characteristic histopathological features [2529]. Therefore larger prospective and comparative series must be evaluated before a general clinical algorithm can be proposed. Meanwhile, in those individual patients where cryobiopsy has revealed the full pattern of UIP, open lung biopsy is unnecessary if histology and clinical data engender a clear diagnosis.

Conclusions

Cryobiopsy could improve the results reported on conventional transbronchial forceps biopsy. Nevertheless, previously reported series are small and prospective comparisons do not exist. Such studies could even reveal that eventually less cryobiopsy pieces per patient are necessary as compared to transbronchial forceps biopsies. For the latter most of the authors recommend four biopsies per bronchoscopy during the processing of diffuse lung disease. In our present series only 1–2 cryobiopsy specimen were sampled as a rule.

The high diagnostic yield and the lack of any major complication in our series encourages one to proceed with larger studies and to establish transbronchial cryobiopsy within routine clinical algorithms in the diagnostic of diffuse, parenchymal lung disease.

Abbreviations

ATS: 

American Thoracic Society

COP: 

Cryptogenic organizing pneumonia

CT: 

Computed tomography

DPLD: 

Diffuse, parenchymal lung disease

ERS: 

European Respiratory Society

HP: 

Hypersensitivity pneumonia

HR-CT: 

High resolution computed tomography

IPF: 

Idiopathic pulmonary fibrosis

NSIP: 

Non specific interstitial pneumonia

pANCA: 

Perinuclear anti-neutrophil cytoplasmic antibodies

RB-ILD: 

Respiratory bronchiolitis associated interstitial lung disease

TBB: 

Transbronchial biopsy

UIP: 

Usual interstitial pneumonia.

Declarations

Acknowledgments

This work is a part of the doctoral thesis of main author Sergej Griff, being performed at the Charité – University of Medicine in Berlin, Germany.

Authors’ Affiliations

(1)
Institute of Pathology, HELIOS Klinikum Emil von Behring
(2)
Clinic of Pneumology, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring
(3)
Medical Clinic of Pneumology, Gemeinschaftskrankenhaus Havelhöhe
(4)
Clinic of Pneumology, HELIOS-Kliniken Schwerin

References

  1. Berbescu EA, Katzenstein AL, Snow JL, Zisman DA: Transbronchial biopsy in usual interstitial pneumonia. Chest. 2006, 129 (5): 1126-1131. 10.1378/chest.129.5.1126.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Katzenstein AL, Askin FB: Interpetation and significance of pathologic findings in transbronchial lung biopsy. Am J Surg Pathol. 1980, 4 (3): 223-234. 10.1097/00000478-198006000-00002.View ArticlePubMedGoogle Scholar
  3. Joyner LR, Scheinhorn DJ: Transbronchial forceps lung biopsy through the fiberotic bronchoscope, diagnosis of diffuse pulmonary disease. Chest. 1975, 67: 532-535. 10.1378/chest.67.5.532.View ArticlePubMedGoogle Scholar
  4. Katzenstein AL: Katzenstein and Askin’s Surgical Pathology of Non-Neoplastic Lung Disease. 2006, Philadelphia, USA: Saunders Company, 4Google Scholar
  5. Zavala DC: Diagnostic fiberoptic bronchoscopy, techniques and results of biopsy in 600 patients. Chest. 1975, 68: 12-19.View ArticlePubMedGoogle Scholar
  6. Fraire AE, Cooper SP, Greenberg SD, Rowland LP, Langston C: Transbronchial lung biopsy: histopathologic and morphometric assessment of diagnostic utility. Chest. 1992, 102: 748-752. 10.1378/chest.102.3.748.View ArticlePubMedGoogle Scholar
  7. Payne CR, Hadfield JW, Stovin PG, Barker V, Heard BE, Stark JE: Diagnostic accuracy of cytology and biopsy in primary bronchial carcinoma. J Clin Pathol. 1981, 34: 773-778. 10.1136/jcp.34.7.773.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Rudd RM, Gellert AR, Boldy DAR, Studdy PR, Pearson MC, Geddes DM, Sinha G: Bronchoscopic and percutaneus aspiration biopsy in the diagnosis of brochial cell type. Thorax. 1982, 37: 462-465. 10.1136/thx.37.6.462.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Franke KJ, Nilius G, Rühle KH: Bronchocopic diagnosis of peripheral pulmonary foci. Dtsch Med Wochenschr. 2006, 131: 2229-2233. 10.1055/s-2006-951358.View ArticlePubMedGoogle Scholar
  10. Descombes E, Gardiol D, Leuenberger P: Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis. 1997, 52 (4): 324-329.PubMedGoogle Scholar
  11. Baaklini WA, Reinoso MA, Gorin AB, Sharafkaneh A, Manian P: Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules. Chest. 2000, 117: 1049-1054. 10.1378/chest.117.4.1049.View ArticlePubMedGoogle Scholar
  12. Schönfeld N, Frank W, Wenig S, Uhrmeister P, Allica E, Preussler H, Grassot A, Loddenkemper R: Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration. 1993, 60 (1): 38-44.View ArticlePubMedGoogle Scholar
  13. Ryu JH, Myers JL, Capizzi SA, Duoglas WW, Vassallo R, Decker PA: Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005, 127: 178-184. 10.1378/chest.127.1.178.View ArticlePubMedGoogle Scholar
  14. Casoni GL, Gurioli C, Chhajed PN, Chilosi M, Zompatori M, Olivieri D, Poletti V: The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease. Monaldi Arch Chest Dis. 2008, 69 (2): 59-64.PubMedGoogle Scholar
  15. Oliveira CC, Fabro AT, Ribeiro SM, Defaveri J, Capelozzi VL, Queluz THT, Yoo HHB: Evaluation of the use of transbronchial biopsy in patients with clinical suspicion of interstitial lung disease. J Bras Pneumol. 2011, 37 (2): 168-175.PubMedGoogle Scholar
  16. Romagnoli M, Bigliazzi C, Casoni G, Chilosi M, Carloni A, Dubini A, Gurioli C, Tomassetti S: The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2008, 25 (1): 36-45.PubMedGoogle Scholar
  17. Shim HS, Park MS, Park IK: Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int. 2010, 60 (5): 373-377. 10.1111/j.1440-1827.2010.02528.x.View ArticlePubMedGoogle Scholar
  18. Franke KJ, Theegarten D, Hann von Weyhern C, Nilius G, Brueckner C, Hetzel J, Hetzel M, Ruhle KH, Enderle MD, Szyrach MN: Prospective controlled animal study on biopsy sampling with new flexible cryoprobes versus forceps: evaluation of biopsy size, histological quality and bleeding risk. Respiration. 2010, 80 (2): 127-132. 10.1159/000287251.View ArticlePubMedGoogle Scholar
  19. Schumann C, Hetzel J, Babiak AJ, Merk T, Wibmer T, Möller P, Lepper PM, Hetzel M: Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg. 2010, 140 (2): 417-421. 10.1016/j.jtcvs.2009.12.028.View ArticlePubMedGoogle Scholar
  20. Griff S, Ammenwerth W, Schönfeld N, Bauer TT, Mairinger R, Blum T, Kollmeier J, Grüning W: Morphometrical analysis of transbronchial cryobiopsies. Diagn Pathol. 2011, 6: 53-10.1186/1746-1596-6-53.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Aktas Z, Gunay E, Hoca NT, Yilmaz A, Demirag F, Gunay S, Sipit T, Kurt EB: Endobronchial cryobiopsy or forceps biopsy for lung cancer diagnosis. Ann Thorac Med. 2010, 5 (4): 242-246. 10.4103/1817-1737.69117.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho D, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Mü̈ller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183: 794-View ArticleGoogle Scholar
  23. American Thoracic Society/European Respiratory Society: International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002, 165: 277-304.View ArticleGoogle Scholar
  24. Silva CI, Müller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A: Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008, 246 (1): 288-297. 10.1148/radiol.2453061881.View ArticlePubMedGoogle Scholar
  25. Takemura T, Akashi T, Kamiya H, Ikushima S, Ando T, Oritsu M, Sawahata M, Ogura T: Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology. 2012, 61 (6): 1026-1035. 10.1111/j.1365-2559.2012.04322.x.View ArticlePubMedGoogle Scholar
  26. Dina R, Sheppard MN: The histological diagnosis of clinically documented cases of cryptogenic organizing pneumonia: diagnostic features in transbronchial biopsies. Histopathology. 1993, 23 (6): 541-545. 10.1111/j.1365-2559.1993.tb01240.x.View ArticlePubMedGoogle Scholar
  27. Jareno Esteban J, Zamora Garcia E, Chillon Martin MJ, Pérez Amor E, Villegas Fernández F, Forniés Menéndez E, Callol Sánchez L: Bronchiolitis obliterans with organizing pneumonia, usefulness and yield of diagnostic techniques and procedures in a series of 20 patients. An Med Interna. 2001, 18 (2): 63-68.PubMedGoogle Scholar
  28. Gerasin VA, Molodtsova VP, Dvorakovskaia IV, Derevianko AV, Bazhanov AA, Baranova OP: Transbronchial biopsy of the lungs in diagnosis of respiratory sarcoidosis. Ter Arkh. 2008, 80 (4): 43-46.PubMedGoogle Scholar
  29. Cucevic I, Cucevic B, Pongrac I, Roglic M: Comparative analysis of bronchoalveolar lavage and transbronchial lung biopsy in pulmonary sarcoidosis. Plucne Bolesti. 1991, 43 (1–2): 106-108.PubMedGoogle Scholar
  30. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/14/171/prepub

Copyright

© Griff et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement